Clinical Trials Directory

Trials / Completed

CompletedNCT02487381

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System, Cognition and Neuronal Oscillations

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Central Institute of Mental Health, Mannheim · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The study evaluates the gene-environment interaction of the COMT-genotype on the effects of the phytocannabinoids delta-9-tetrahydrocannabinol, cannabidiol or a combination of both on induction of psychotic symptoms, endocannabinoid levels in human body fluids, neuronal processing, and neural oscillations. In addition the effects of the phytocannabinoids on lipid levels in serum and cerebrospinal fluid, cognition, neural synchrony and neuronal processing assessed by EEG and fMRI.

Conditions

Interventions

TypeNameDescription
DRUGdelta-9-tetrahydrocannabinol
DRUGCannabidiol
DRUGPlacebo

Timeline

Start date
2015-04-01
Primary completion
2015-07-01
Completion
2015-08-01
First posted
2015-07-01
Last updated
2015-08-17

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02487381. Inclusion in this directory is not an endorsement.